PRELUDE CAPITAL MANAGEMENT, LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 89 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$0
-100.0%
141
-32.5%
0.00%
Q3 2018$1,000209
+167.9%
0.00%
Q2 2018$0
-100.0%
78
-99.9%
0.00%
-100.0%
Q1 2018$381,000
+3.8%
131,5010.0%0.03%
-3.4%
Q4 2017$367,000
+14.7%
131,501
+49.9%
0.03%0.0%
Q3 2017$320,000
+3455.6%
87,709
+2148.9%
0.03%
+2800.0%
Q2 2017$9,000
+800.0%
3,900
+290.0%
0.00%
Q3 2016$1,000
-50.0%
1,000
-37.5%
0.00%
Q2 2016$2,0000.0%1,600
+33.3%
0.00%
Q1 2014$2,0001,2000.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 20,896,038$17,135,0000.89%
X-Square Capital, LLC 270,680$222,0000.15%
New Leaf Venture Partners, L.L.C. 402,118$330,0000.09%
GSA CAPITAL PARTNERS LLP 688,431$565,0000.06%
EXCALIBUR MANAGEMENT CORP 51,000$42,0000.04%
WealthTrust Axiom LLC 138,505$113,0000.04%
Caption Management, LLC 855,200$701,0000.04%
Evercore Wealth Management, LLC 418,414$343,0000.01%
Gemmer Asset Management LLC 1,939$32,0000.01%
Ausdal Financial Partners, Inc. 23,000$19,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders